Sector ratings Harmony Biosciences Holdings, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-05 pm EST			5-day change	1st Jan Change
39.83 ^USD	+4.13%		+12.86%	+15.75%

Dec. 01	Mizuho Raises Price Target on Harmony Biosciences Holdings to $46 From $39, Keeps Outperform Rating	MT
Nov. 24	Harmony Biosciences to Submit NDA for Narcolepsy Treatment Following Trial Results	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
HARMONY BIOSCIENCES HOLDINGS, INC.	2.29B		BB
ELI LILLY AND COMPANY	905B		A
JOHNSON & JOHNSON	487B		BBB
ABBVIE INC.	400B		AA
ROCHE HOLDING AG	330B		AA
ASTRAZENECA PLC	281B		A
NOVARTIS AG	255B		AAA
MERCK & CO., INC.	248B		A
NOVO NORDISK A/S	214B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	150B		AAA
PFIZER INC.	148B		BBB
SANOFI	120B		A
VERTEX PHARMACEUTICALS INCORPORATED	116B		AA
BRISTOL-MYERS SQUIBB COMPANY	106B		A
GSK PLC	96.52B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	87.18B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
ALNYLAM PHARMACEUTICALS, INC.	60.52B		AA	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	57.93B		AA
Average	215.25B		AA
Weighted average by Cap.			AA